AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 02/03/23

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $64.36 million
NAV $27.39
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 02/03/23

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 2,350,000
Number of Holdings 97
30-Day Median Bid-Ask Spread 0.27%

Distributions As of 02/03/23

30-Day SEC Yield 0.86%
Distribution Frequency Semi-Annually

ETF Prices As of 02/03/23

NAV $27.39 Daily Change $0.00 0.00%
Market Price $27.25 Daily Change -$0.04 -0.15%

Performance History

As of recent
(12/31/22)
As of recent
(12/31/22)
Fund NAV Market Price Index
1 Year -8.52% -8.64% -8.36%
3 Years 4.18% 4.14% 4.39%
5 Years 7.01% 6.89% 7.22%
Since Inception 9.34% 9.65% 9.62%
1 Year 1.75% 1.37% 1.93%
3 Years 5.47% 5.28% 5.69%
5 Years 6.04% 6.00% 6.25%
Since Inception 9.65% 9.96% 9.93%
Year-to-Date -8.52% -8.64% -8.36%
1 Month -0.75% -1.42% -0.70%
3 Months 11.66% 11.59% 11.71%
Since Inception 81.07% 84.53% 84.12%
Year-to-Date 2.71% 2.71% 2.73%
1 Month 2.71% 2.71% 2.73%
3 Months 8.06% 8.12% 8.13%
Since Inception 85.97% 89.53% 89.16%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 02/03/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.87 NOVOB DC NOVO NORDISK A/S-B BHC8X90 137.32 18,149 2,492,183.67
3.61 LLY ELI LILLY & CO 2516152 339.08 6,856 2,324,732.48
3.61 REGN REGENERON PHARMACEUTICALS 2730190 783.13 2,964 2,321,197.32
3.56 BSX BOSTON SCIENTIFIC CORP 2113434 48.50 47,196 2,289,006.00
3.44 SYK STRYKER CORP 2853688 283.14 7,813 2,212,172.82
3.23 BMY BRISTOL-MYERS SQUIBB CO 2126335 74.45 27,932 2,079,537.40
3.21 AMGN AMGEN INC 2023607 245.17 8,430 2,066,783.10
3.15 ALC SW ALCON INC BJT1GR5 76.35 26,591 2,030,098.13
3.01 AZN ASTRAZENECA PLC-SPONS ADR 2989044 63.44 30,483 1,933,841.52
2.95 JNJ JOHNSON & JOHNSON 2475833 164.61 11,533 1,898,447.13
2.91 BIIB BIOGEN INC 2455965 283.63 6,600 1,871,958.00
2.81 ABBV ABBVIE INC B92SR70 145.20 12,453 1,808,175.60
2.78 DXCM DEXCOM INC B0796X4 108.43 16,491 1,788,119.13
2.56 4519 JP CHUGAI PHARMA CO 6196408 25.77 63,827 1,644,870.11
2.55 WELL WELLTOWER INC BYVYHH4 75.82 21,653 1,641,730.46
2.55 MDT MEDTRONIC PLC BTN1Y11 87.10 18,817 1,638,960.70
2.51 RO SW ROCHE HOLDING AG-BR 7108918 354.63 4,556 1,615,697.39
2.23 EW EDWARDS LIFESCIENCES CORP 2567116 82.12 17,447 1,432,747.64
1.89 ZBH ZIMMER BIOMET HO 2783815 129.45 9,410 1,218,124.50
1.85 BGNE BEIGENE LTD-ADR BYYWPW6 256.90 4,627 1,188,676.30
1.85 4503 JP ASTELLAS PHARMA INC 6985383 14.42 82,394 1,188,060.62
1.79 GMAB DC GENMAB A/S 4595739 388.11 2,973 1,153,843.23
1.76 SGEN SEAGEN INC BLPK4D2 138.00 8,225 1,135,050.00
1.59 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 143.99 7,125 1,025,910.42
1.54 4543 JP TERUMO CORP 6885074 29.11 34,054 991,162.67
1.47 VTR VENTAS INC 2927925 52.60 17,935 943,381.00
1.42 PODD INSULET CORP B1XGNW4 295.19 3,094 913,317.86
1.37 068270 KS CELLTRION INC B0C5YV1 137.55 6,418 882,758.67
1.29 INCY INCYTE CORP 2471950 83.61 9,927 829,996.47
1.18 SOON SW SONOVA HOLDING AG-REG 7156036 267.71 2,834 758,682.06
1.11 UCB BB UCB SA 5596991 81.54 8,731 711,926.02
0.88 SN/ LN SMITH & NEPHEW PLC 0922320 14.38 39,294 565,169.10
0.86 3692 HK HANSOH PHARMACEU BJYKB72 2.09 263,443 550,035.86
0.85 TFX TELEFLEX INC 2881407 258.47 2,111 545,630.17
0.81 EXAS EXACT SCIENCES CORP 2719951 67.45 7,766 523,816.70
0.80 UTHR UNITED THERAPEUTICS CORP 2430412 252.80 2,043 516,470.40
0.79 FME GR FRESENIUS MEDICA 5129074 38.66 13,099 506,455.22
0.73 NBIX NEUROCRINE BIOSC 2623911 110.03 4,266 469,387.98
0.72 1858 HK BEIJING CHUNLI-H BVVPXP6 2.73 170,266 465,527.86
0.72 COH AU COCHLEAR LTD 6211798 154.83 2,990 462,935.99
0.69 NVCR NOVOCURE LTD BYSS4X4 94.22 4,698 442,645.56
0.63 FGEN FIBROGEN INC BSDRYR8 24.57 16,431 403,709.67
0.62 AGL AGILON HEALTH INC BLR4TK4 22.05 18,061 398,245.05
0.58 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 1.15 326,989 375,116.44
0.57 DVA DAVITA INC 2898087 85.48 4,298 367,393.04
0.54 DEMANT DC DEMANT A/S BZ01RF1 31.91 10,804 344,777.50
0.50 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.56 579,824 324,452.52
0.50 HALO HALOZYME THERAPEUTICS INC 2975098 52.65 6,137 323,113.05
0.48 853 HK MICROPORT SCIENTIFIC CORP B676TW7 3.36 91,802 308,335.27
0.48 OHI OMEGA HEALTHCARE 2043274 28.72 10,719 307,849.68
0.48 AMP IM AMPLIFON SPA B14NJ71 30.23 10,157 307,019.26
0.43 MNKD MANNKIND CORP BF081J4 5.18 53,629 277,798.22
0.42 SILK SILK ROAD MEDICAL INC BGHVXJ7 54.81 4,908 269,007.48
0.39 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.42 609,892 253,431.73
0.39 EXEL EXELIXIS INC 2576941 17.55 14,357 251,965.35
0.37 MMSI MERIT MEDICAL SYSTEMS INC 2580555 73.33 3,241 237,662.53
0.36 2500 HK VENUS MEDTECH -H BL6V047 2.13 109,940 234,025.21
0.36 ENSG ENSIGN GROUP INC/THE B1YWPP8 92.40 2,513 232,201.20
0.36 TBPH THERAVANCE BIOPHARMA INC BMNDK09 10.65 21,632 230,380.80
0.35 LHCG LHC GROUP INC B06DT50 158.65 1,415 224,489.75
0.34 ATEC ALPHATEC HOLDINGS INC BD60BG7 13.48 16,394 220,991.12
0.34 NHI NATL HEALTH INVESTORS INC 2626125 59.17 3,731 220,763.27
0.34 LTC LTC PROPERTIES INC 2498788 38.31 5,628 215,608.68
0.33 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 30.20 7,028 212,245.60
0.32 SBRA SABRA HEALTH CAR B5NLBP6 13.59 15,094 205,127.46
0.32 SGHT SIGHT SCIENCES INC BN2T5Q6 11.54 17,668 203,888.72
0.31 ITGR INTEGER HOLDINGS CORP BD06LM7 73.50 2,749 202,051.50
0.31 EKTAB SS ELEKTA AB-B SHS B0M42T2 7.47 27,029 201,883.95
0.31 DNLI DENALI THERAPEUTICS INC BD2B4V0 31.70 6,310 200,027.00
0.31 4547 JP KISSEI PHARM CO 6494061 18.77 10,570 198,429.49
0.30 8086 JP NIPRO CORP 6641599 7.84 24,837 194,844.60
0.29 NUVA NUVASIVE INC B00GJC2 48.12 3,869 186,176.28
0.29 NHC NATIONAL HEALTHCARE CORP 2139731 61.91 2,968 183,748.88
0.28 GKOS GLAUKOS CORP BYMWL19 51.52 3,493 179,959.36
0.27 GN DC GN STORE NORD A/S 4501093 27.68 6,242 172,747.82
0.27 PHM SM PHARMA MAR SA BMW2GT8 66.51 2,560 170,273.83
0.26 INGN INOGEN INC BJSVLL5 26.00 6,378 165,828.00
0.24 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 9.16 16,563 151,648.37
0.23 ACAD ACADIA PHARMACEU 2713317 19.83 7,586 150,430.38
0.23 LIVN LIVANOVA PLC BYMT0J1 58.14 2,568 149,303.52
0.23 AED BB AEDIFICA B1G5XP1 90.82 1,618 146,951.97
0.23 CSH-U CN CHARTWELL RETIRE B8S8C94 7.34 20,022 146,924.35
0.22 PNTG PENNANT GROUP INC/THE BKTC976 12.76 11,293 144,098.68
0.22 RYM NZ RYMAN HEALTHCARE LTD 6161525 4.27 32,852 140,362.72
0.22 ALEC ALECTOR INC BJ4LDC4 9.49 14,683 139,341.67
0.21 BPMC BLUEPRINT MEDICINES CORP BWY52P3 45.65 2,986 136,310.90
0.21 AMED AMEDISYS INC 2024332 92.14 1,448 133,418.72
0.20 ANGO ANGIODYNAMICS INC B00CR04 13.43 9,595 128,860.85
0.19 CMAX CAREMAX INC BMD9BG0 4.53 27,119 122,849.07
0.16 AMRN AMARIN CORP PLC -ADR 2301938 1.89 55,853 105,562.17
0.15 HRTX HERON THERAPEUTICS INC BJ0XLZ3 2.84 32,757 93,029.88
0.14 KORI FP KORIAN B1HKRM0 9.78 9,506 92,993.70
0.13 BKD BROOKDALE SR B0PZN33 2.80 30,346 84,968.80
0.13 CASH 1.00 81,880 81,879.88
0.09 CANO CANO HEALTH INC BN0WWW2 1.49 36,847 54,902.03
0.08 DHC DIVERSIFIED HEAL BKRN595 0.75 71,357 53,160.97
0.03 ORP FP ORPEA 7339451 3.02 5,277 15,916.60
0.00 EURO 1.09 1 1.39
0.00 BRITISH STERLING POUND 1.17 0 0.07
0.00 DANISH KRONE 0.00 0 0.00
0.00 HONG KONG DOLLAR 0.00 0 0.00
0.00 KOREAN WON 0.00 0 0.00
0.00 SWEDISH KRONE 0.00 0 0.00
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.00
0.00 JAPANESE YEN 0.01 -2 -0.02
0.00 SWISS FRANC 1.00 0 -0.03
0.00 AUSTRALIAN DOLLAR 0.69 0 -0.09
0.00 CANADIAN DOLLAR 0.74 0 -0.28
Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 12/31/22

Sector Weight (%)
Health Care 94.7
Real Estate 5.3

Source: AltaVista Research, LLC

Country Breakdown As of 12/31/22

Country Weight (%)
United States 59.2
Switzerland 8.2
Japan 6.9
Denmark 6.7
China 5.2
Britain 5.0
Ireland 2.5
South Korea 1.3
Belgium 1.3
Germany 0.7
Australia 0.7
Other/Cash 2.3

Source: AltaVista Research, LLC

ETF Characteristics As of 02/03/23

Return on Equity 13.10%
Weighted Avg. Market Cap 61,168 M
2022 2023
Price-to-earnings 28.31 25.15
Price-to-book value 3.42 3.18

Source: AltaVista Research, LLC

ETF Risk Stats As of 01/31/23

Versus Beta
S&P 500 0.71
MSCI EAFE 0.71
MSCI Emg. Mkts 0.56
Standard Deviation 18.60%

Source: AltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Back to Top